WuXi Advanced Therapies’ combination of flexible service options, advanced capabilities, unmatched expertise and state-of-the-art facilities provides cell therapy clients a distinct advantage: a unique single-source for cellular therapeutics services — from procurement, process development, cell expansion, and fill/finish to comprehensive product testing and release.

1. Cell
Therapy
Services

2. WuXi Advanced Therapies’combination of flexible
service options, advanced capabilities, unmatched
expertise and state-of-the-art facilities provides
cell therapy clients a distinct advantage: a unique
single-source for cellular therapeutics services —
from procurement, process development, cell
expansion, and fill/finish to comprehensive
product testing and release.
experience
Our preclinical services for cell therapies and vaccines
leverage a unique mix of scientific and regulatory
expertise in virology, bioanalytical assays, and other
studies. Extensive staff experience, state-of- the-art
facilities and broad understanding of advanced
therapeutic development will support your IND.
Exceptional Preclinical
Expertise
Cell Therapies Testing & Manufacturing
Discovery Clinical / CommercialPre-Clinical / Development
Animal
Models
Cell Source
Characteri-
zaton
Assay
Development
Safety /
Toxicology
Process
Development
Bioanalytical
Services
Small-Scale
Manufacturing
Scale-Up /
Process
Optimization
Technology
Transfer
Aseptic Process
Validation
Product
Release /
Stability
Testing
cGMP
Manufacturing
Services for Cell Therapies
We provide an integrated set of services and the
capacity needed to get cell therapy products to
market with the shortest timeline possible.
With decades of experience in the testing of biothera-
peutics, WuXi Advanced Therapies offers unparalleled
capacity and guidance to reduce time to clinic. We
provide the full spectrum of testing services, including
rapid methods for products with limited stability. As
a unique single-source, fully integrated CDMO, we
support cellular therapeutics from procurement to
comprehensive product testing and release.
Advanced Testing
Capabilities
Our state-of-the-art facilities provide adaptable manu-
facturing solutions and optimized flexibility utilizing
our integrated services. With current space comprising
dozens of GMP manufacturing suites and hundreds of
thousands of square feet, we have the capacity to
support autologous and allogeneic programs in both
early stage and late stage, with the additional resources
needed to support commercial volumes.
Our cell and tissue experience is second to none, and
includes the following:
RPE cells
hES cells
Autologous human progenitor cell product
MSC products
Human tumor cell lines (cancer vaccine products)
Tumor-activated NK cells
CAR-T cell therapies
Flexibility & State-of-the-Art
Manufacturing Facilities
Broad-Based Cell
Experience
Cell culture production options include the following:
Nunc™ Cell Factory™ / Corning® CellStack®
Corning® HyperFlask® and HyperStack®
WAVE systems
Custom tube sets
Bag manifold systems
Single-use tangential flow filtration
Single-use bioreactor systems
T-Flasks and roller bottles
Cell Culture
Production Options

3. WuXi Advanced Therapies’combination of flexible
service options, advanced capabilities, unmatched
expertise and state-of-the-art facilities provides
cell therapy clients a distinct advantage: a unique
single-source for cellular therapeutics services —
from procurement, process development, cell
expansion, and fill/finish to comprehensive
product testing and release.
experience
Our preclinical services for cell therapies and vaccines
leverage a unique mix of scientific and regulatory
expertise in virology, bioanalytical assays, and other
studies. Extensive staff experience, state-of- the-art
facilities and broad understanding of advanced
therapeutic development will support your IND.
Exceptional Preclinical
Expertise
Cell Therapies Testing & Manufacturing
Discovery Clinical / CommercialPre-Clinical / Development
Animal
Models
Cell Source
Characteri-
zaton
Assay
Development
Safety /
Toxicology
Process
Development
Bioanalytical
Services
Small-Scale
Manufacturing
Scale-Up /
Process
Optimization
Technology
Transfer
Aseptic Process
Validation
Product
Release /
Stability
Testing
cGMP
Manufacturing
Services for Cell Therapies
We provide an integrated set of services and the
capacity needed to get cell therapy products to
market with the shortest timeline possible.
With decades of experience in the testing of biothera-
peutics, WuXi Advanced Therapies offers unparalleled
capacity and guidance to reduce time to clinic. We
provide the full spectrum of testing services, including
rapid methods for products with limited stability. As
a unique single-source, fully integrated CDMO, we
support cellular therapeutics from procurement to
comprehensive product testing and release.
Advanced Testing
Capabilities
Our state-of-the-art facilities provide adaptable manu-
facturing solutions and optimized flexibility utilizing
our integrated services. With current space comprising
dozens of GMP manufacturing suites and hundreds of
thousands of square feet, we have the capacity to
support autologous and allogeneic programs in both
early stage and late stage, with the additional resources
needed to support commercial volumes.
Our cell and tissue experience is second to none, and
includes the following:
RPE cells
hES cells
Autologous human progenitor cell product
MSC products
Human tumor cell lines (cancer vaccine products)
Tumor-activated NK cells
CAR-T cell therapies
Flexibility & State-of-the-Art
Manufacturing Facilities
Broad-Based Cell
Experience
Cell culture production options include the following:
Nunc™ Cell Factory™ / Corning® CellStack®
Corning® HyperFlask® and HyperStack®
WAVE systems
Custom tube sets
Bag manifold systems
Single-use tangential flow filtration
Single-use bioreactor systems
T-Flasks and roller bottles
Cell Culture
Production Options

4. The Advanced Therapies business unit of WuXi AppTec is a
global Contract Development and Manufacturing Organization
dedicated to accelerating and transforming development, manufacturing,
and commercialization of cell, gene, and other advanced therapies.
Accelerating Progress
and Time to Market
Integrated CDMO and Testing Service Platform
advancedtherapies.com
CONNECT WITH US
WuXiATU-105-110118